Thursday 27 September 2018

Topic- Hemophagocytic Lymphohistiocytosis: A New Foe (PAPN) - Lupine Publishers

Hemophagocytic lymphohistiocytosis (HLH) is an aggressive and life-threatening syndrome of excessive immune activation. It commonly affects infants from birth to 18 months of age, but the disease can be seen in children and adults of all ages. HLH can occur as a familial or sporadic disorder, and it can be triggered by a variety of events that disrupt immune homeostasis. Prompt recognition of the disease and initiation of treatment is essential for the survival of affected patients [1].

No comments:

Post a Comment

Note: only a member of this blog may post a comment.